Femoral Neck Fractures, Inflammatory Response, Postoperative Cognitive Dysfunction, Postoperative Complications, Postoperative Delirium
Conditions
Brief summary
Hip fractures incidence grows rapidly with the aging of the population. After indicated surgical treatment, hip fracture patients experience high rates of postoperative complications, postoperative delirium (PD), postoperative cognitive dysfunction (POCD), leading to poor postoperative recovery during hospitalization, which can cause disability, distress for both patients and their families, are associated with other medical complications and account for significant additional health care costs. We currently use dexmedetomidine in elderly patients with hip fractures undergoing hip hemi-arthroplasty in order to improve postoperative recovery and prevent and treating PD and POCD. Dexmedetomidine is a drug used for sedation in critically ill patients that provides some pain relief and controls the bodies response to stress. The sedation produced by dexmedetomidine appears more similar to natural sleep than any other drug used for anesthesia and postoperative sedation. Data suggesting that dexmedetomidine can prevent delirium following cardiac surgery and the developing understanding of the causes of PD and POCD suggest that dexmedetomidine will be particularly effective.
Interventions
PROCEDUREhip arthroplasty
Every patient with femoral neck fractures must undergo hip hemi-arthroplasty.
DRUGTotal Intravenous Anesthesia and Peripheral nerve blocks
Every patient receives Peripheral nerve blocks and Total Intravenous Anesthesia with propofol
Sponsors
Chinese PLA General Hospital
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
75 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Age \> 75years old * Patients with femoral neck fractures * Undergoing hip hemi-arthroplasty surgery * American Society of Anesthesiologists (ASA) physical status II-IV * MoCA being more than 23
Exclusion criteria
* Patient refusal to participate in the study * Patient refusal or failure of regional block * allergic to local anesthetics or general anesthetics * history of opioid dependence * contraindications to nerve blocks (coagulation defects, infection at puncture site, preexisting neurological deficits in the lower extremities) * current severe psychiatric disease or alcoholism or drug dependence * severe visual or auditory disorder
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| postoperative cognitive dysfunction(POCD) | 7days | POCD is assessed by Montreal Cognitive Assessment(MoCA), which was designed as a rapid screening instrument for mild cognitive dysfunction. It assesses different cognitive domains: attention and concentration,executive functions, memory, language,visuoconstructional skills, conceptual thinking,calculations, and orientation. Time to administer the MoCA is approximately 10 minutes. The total possible score is 30 points; a score of 26 or above is considered normal. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Postoperative recovery | 7days | The postoperative recovery is assessed by the Post-operative Quality Recovery Scale (PQRS),which is a research tool designed to measure postoperative quality of recovery in multiple domains and over multiple time periods. Recovery domains include physiological, emotive (depression and anxiety), nociceptive (pain and nausea), cognitive, activities of daily living (ADL), and overall patient perspective (including satisfaction). |
| Postoperative Delirium(PD) | 72 hours | The postoperative Delirium is assessed by the Confusion Assessment Method (CAM) |
Other
| Measure | Time frame | Description |
|---|---|---|
| postoperative complications | 7 days | — |
| MB isoenzyme of creatine kinase and blood sugar | 7 days | — |
| perioperative opioid consumption | 3 days | Intraoperative and postoperative opioid consumption were calculated between the two groups. |
| IL-6 and C-reacting protein | 7 days | — |
Countries
China
Contacts
Primary Contactzhang hong, ph.d
Backup Contactyuan weixiu, ph.d
Outcome results
None listed